MRVI FY 2023 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$289M-67.3% YoY

Gross Profit

$140M48.5% margin

Operating Income

-$32M-11.0% margin

Net Income

-$119M-41.2% margin

EPS (Diluted)

$-0.90

Cash Flow

Operating Cash Flow

$126M

Free Cash Flow

$61M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$698M

Stockholders' Equity

$417M

Cash & Equivalents

$575M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$289M	$883M	-67.3%
Gross Profit	$140M	$714M	-80.4%
Operating Income	-$32M	$574M	-105.5%
Net Income	-$119M	$220M	-154.1%